---
annotations:
- type: Pathway Ontology
  value: infectious disease pathway
- type: Pathway Ontology
  value: disease pathway
- type: Disease Ontology
  value: severe acute respiratory syndrome
- type: Disease Ontology
  value: viral infectious disease
authors:
- ReactomeTeam
- DeSl
description: The SARS-CoV-1 coronavirus is the causative agent of the outbreak of
  severe acute respiratory syndrome in 2003 that caused 8,098 known cases of the disease
  and 774 deaths. The molecular events involved in viral infection and the response
  of the human host to it have since been studied in detail and are annotated here
  (de Wit et al. 2016; Marra et al. 2003). The SARS-CoV-1 viral infection pathway
  here uses entries listed in the UniProt "Human SARS coronavirus (SARS-CoV) (Severe
  acute respiratory syndrome coronavirus)" taxonomy.<br><br>SARS-CoV-1 infection begins
  with the binding of viral S (spike) protein to cell surface angiotensin converting
  enzyme 2 (ACE2) and endocytosis of the bound virion. Within the endocytic vesicle,
  host proteases mediate cleavage of S protein into S1 and S2 fragments, leading to
  S2-mediated fusion of the viral and host endosome membranes and release of the viral
  capsid into the host cell cytosol. The capsid is uncoated to free the viral genomic
  RNA, whose cap-dependent translation produces polyprotein pp1a and, by means of
  a 1-base frameshift, polyprotein pp1ab. Autoproteolytic cleavage of pp1a and pp1ab
  generates 15 or 16 nonstructural proteins (nsps) with various functions. Importantly,
  the RNA dependent RNA polymerase (RdRP) activity is encoded in nsp12. Nsp3, 4, and
  6 induce rearrangement of the cellular endoplasmic reticulum membrane to form cytosolic
  double membrane vesicles (DMVs) where the viral replication transcription complex
  is assembled and anchored. With viral genomic RNA as a template, viral replicase-transcriptase
  synthesizes a full length negative sense antigenome, which in turn serves as a template
  for the synthesis of new genomic RNA. The replicase-transcriptase can also switch
  template during discontinuous transcription of the genome at transcription regulated
  sequences to produce a nested set of negative-sense subgenomic (sg) RNAs, which
  are used as templates for the synthesis of positive-sense sgRNAs that are translated
  to generate viral proteins. Finally, viral particle assembly occurs in the ER Golgi
  intermediate compartment (ERGIC). Viral M protein provides the scaffold for virion
  morphogenesis (Fung & Liu 2019; Masters 2006).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9678108
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5020
- /instance/WP5020
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5020.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The SARS-CoV-1 coronavirus is the causative agent of the outbreak of
    severe acute respiratory syndrome in 2003 that caused 8,098 known cases of the
    disease and 774 deaths. The molecular events involved in viral infection and the
    response of the human host to it have since been studied in detail and are annotated
    here (de Wit et al. 2016; Marra et al. 2003). The SARS-CoV-1 viral infection pathway
    here uses entries listed in the UniProt "Human SARS coronavirus (SARS-CoV) (Severe
    acute respiratory syndrome coronavirus)" taxonomy.<br><br>SARS-CoV-1 infection
    begins with the binding of viral S (spike) protein to cell surface angiotensin
    converting enzyme 2 (ACE2) and endocytosis of the bound virion. Within the endocytic
    vesicle, host proteases mediate cleavage of S protein into S1 and S2 fragments,
    leading to S2-mediated fusion of the viral and host endosome membranes and release
    of the viral capsid into the host cell cytosol. The capsid is uncoated to free
    the viral genomic RNA, whose cap-dependent translation produces polyprotein pp1a
    and, by means of a 1-base frameshift, polyprotein pp1ab. Autoproteolytic cleavage
    of pp1a and pp1ab generates 15 or 16 nonstructural proteins (nsps) with various
    functions. Importantly, the RNA dependent RNA polymerase (RdRP) activity is encoded
    in nsp12. Nsp3, 4, and 6 induce rearrangement of the cellular endoplasmic reticulum
    membrane to form cytosolic double membrane vesicles (DMVs) where the viral replication
    transcription complex is assembled and anchored. With viral genomic RNA as a template,
    viral replicase-transcriptase synthesizes a full length negative sense antigenome,
    which in turn serves as a template for the synthesis of new genomic RNA. The replicase-transcriptase
    can also switch template during discontinuous transcription of the genome at transcription
    regulated sequences to produce a nested set of negative-sense subgenomic (sg)
    RNAs, which are used as templates for the synthesis of positive-sense sgRNAs that
    are translated to generate viral proteins. Finally, viral particle assembly occurs
    in the ER Golgi intermediate compartment (ERGIC). Viral M protein provides the
    scaffold for virion morphogenesis (Fung & Liu 2019; Masters 2006).  View original
    pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9678108 Reactome].
  keywords:
  - N-glycan E
  - 'pp1ab-nsp9 '
  - ADPr-p-S177-Ncap
  - 3a:membranous
  - pentamer
  - 'pp1ab-nsp13 '
  - nsp10
  - dimer:Î±-Ketoamides
  - GSK3B
  - VHL
  - 'M '
  - nsp3:nsp4
  - nsp8
  - 'UBC(153-228) '
  - 'mRNA3 minus strand '
  - strand):RTC:RTC
  - glycosylated-ACE2
  - 'pp1ab-nsp16 '
  - a nucleotide sugar
  - 'compound 11r '
  - 'm7G(5'')pppAm-mRNA8 '
  - UDP-GalNAc
  - 'pp1a-nsp10 '
  - nsp16:nsp10
  - 'm7GpppA-mRNA3 '
  - nsp3
  - m7G(5')pppAm-capped,polyadenylated mRNA2
  - '1-deoxynojirimycin '
  - N
  - H2O
  - pp1ab-nsp9
  - pp1ab-nsp1-4
  - strand:RTC
  - M
  - 'CTSL(292-333) '
  - 3xPalmC-E
  - lattice:E
  - SUMO1:C93-UBE2I
  - pp1a-nsp6-11
  - nucleoside
  - 3CLp
  - 'm7G(5'')pppAm-capped, polyadenylated SARS-CoV-1 genomic RNA (plus strand) '
  - mRNAs
  - 'ST6GALNAC4 '
  - nsp15:RB1
  - 'pp1a-nsp6 '
  - 'PARP9 '
  - Cathepsin L1
  - 'm7GpppA-mRNA6 '
  - subgenomic mRNAs
  - protein:encapsidated SARS coronavirus genomic RNA
  - SUMO-p-Ncap dimer
  - 'm7G(5'')pppAm-mRNA4 '
  - 'pp1ab-nsp15 '
  - pp1ab-nsp12
  - 'pp1a-nsp9 '
  - 'mefloquine '
  - 'Host Derived Lipid Bilayer Membrane '
  - m7G(5')pppAm-capped,polyadenylated mRNA3
  - CTSL inhibitors
  - 'pp1ab-nsp5 '
  - 'ST3GAL4 '
  - 'CHMP4B '
  - 'RB1 '
  - S-adenosyl-L-methionine
  - 3CLp dimer
  - 'UVRAG '
  - with mismatched
  - gRNA with secondary
  - 'CHMP4C '
  - 'pp1ab-nsp14 '
  - N-glycan nsp3
  - pp1a-nsp1-4
  - O-glycosyl 3a
  - 'pp1a-nsp4 '
  - 'RNA primer '
  - 'pp1ab-nsp12 '
  - strand):RTC
  - nsp2
  - m7G(5')pppAm-capped
  - 'pp1a-nsp8 '
  - 'm7GpppA-mRNA2 '
  - 'UBC(381-456) '
  - nsp3:nsp4:nsp6
  - MGAT1
  - gRNA
  - 'pp1ab-nsp1-4 '
  - TMPRSS2 inhibitors
  - nsp7:nsp8:nsp12
  - m7GpppA-capped
  - trimer
  - 'm7G(5'')pppAm-capped,polyadenylated mRNA2 '
  - 'mRNA4 minus strand '
  - trimmed
  - nsp7:nsp8:nsp12:nsp14:nsp10:nsp13
  - 'm7G(5'')pppAm-mRNA2 '
  - ZCRB1:SARS-CoV-1
  - 'UBC(609-684) '
  - Spike
  - ZCRB1
  - 'm7G(5'')pppAm-capped,polyadenylated mRNA7 '
  - nsp5
  - 'pp1a-nsp2 '
  - DDX5
  - CMP-Neu5Ac
  - 'SARS coronavirus nascent genomic RNA complement (minus strand) with mismatched
    3'' nucleotide '
  - m7GpppA-SARS-CoV-1
  - coronavirus genomic
  - 8b
  - 'CHMP3 '
  - pp1ab-nsp6
  - pp1ab-nsp15
  - 'mRNA6 minus strand '
  - polyadenylated
  - 'S1:S2:M:E:encapsidated SARS coronavirus genomic RNA: 7a:O-glycosyl 3a tetramer'
  - 'N-glycan pp1a-nsp3-4 '
  - 'm7GpppA-mRNA5 '
  - m7G(5')pppAm-SARS-CoV-1 plus strand subgenomic mRNAs
  - pp1ab-nsp14
  - SARS-CoV-1 plus
  - CTSL:CTSL inhibitors
  - 'TMPRSS2 '
  - glycosylated-ACE2:ACE2 inhibitors
  - p-S177-Ncap
  - genomic
  - 'PARP16 '
  - 'pp1a-nsp3 '
  - gRNA:RTC:RNA
  - 'UBE2I-G97-SUMO1 '
  - 'm7G(5'')pppAm-mRNA5 '
  - 'UBC(457-532) '
  - 'm7G(5'')pppAm-capped,polyadenylated mRNA6 '
  - secondary
  - 'N-glycan pp1ab-nsp3-4 '
  - 'CHMP2A '
  - nascent Spike
  - 'mRNA8 minus strand '
  - 'm7GpppA-mRNA4 '
  - complex
  - 'ZCRB1 '
  - 'pp1a-nsp1 '
  - pp1a-nsp10
  - RB1
  - (plus strand)
  - pp1ab
  - with
  - 'pp1a-nsp5 '
  - RNA complement
  - Ncap
  - 'CHMP4A '
  - nsp4
  - (minus strand)
  - ADP
  - ER
  - nsp7:nsp8:nsp12:nsp14:nsp10:nsp13:nsp15
  - SUMO1-K62-ADPr-p-S177-Ncap
  - 'm7G(5'')pppAm-capped,polyadenylated mRNA4 '
  - structure:RTC
  - TMPRSS2
  - GSK3B:GSKi
  - 'm7GpppA-mRNA7 '
  - 'UBC(305-380) '
  - nsp7
  - UDP
  - SARS-CoV-1 minus
  - pp1a-nsp11
  - 'SARS-CoV-1 genomic RNA (plus strand) '
  - coronavirus
  - 'm7G(5'')pppAm-mRNA3 '
  - 'pp1ab-nsp4 '
  - nsp6
  - Ub-3xPalmC-E
  - strand)
  - primer:RTC
  - UDP-N-acetyl-alpha-D-glucosamine(2âˆ’)
  - pp1a-nsp9
  - palmitoyl-CoA
  - 'RNA:'
  - 'UBC(533-608) '
  - 'UBC(229-304) '
  - NAD+
  - 3a
  - GALNT1
  - RNA
  - nsp10:nsp14
  - 'MOGS '
  - 9b
  - 'mRNA2 minus strand '
  - CoA-SH
  - S3:M:E:encapsidated
  - 'ST3GAL3 '
  - encapsidated SARS
  - 'BECN1 '
  - pp1a-nsp8
  - 'SUMO1-K62-ADPr-p-S177-Ncap '
  - pp1ab-nsp16
  - '7a '
  - ACE2
  - 'mRNA5 minus strand '
  - 'DDX5 '
  - nsp1-4
  - 'pp1ab-nsp10 '
  - 'PRKCSH '
  - 'mRNA9 minus strand '
  - sialyltransferases
  - 'S1:S2:M:E:'
  - 'CHMP7 '
  - pp1a-nsp5
  - ACE2 inhibitors
  - SARS-CoV-1 genomic
  - 7a:O-glycosyl 3a
  - tetramer:glycosylated-ACE2
  - 'genomic RNA:'
  - Ub
  - structure:RTC:nascent RNA minus strand
  - 'SARS-CoV-1 nascent genomic RNA complement (minus strand) '
  - trimmed N-glycan
  - 'N-glycan pp1a-nsp3 '
  - pp1a dimer
  - 'mRNA9 '
  - nsp9
  - 'mRNA7 minus strand '
  - alpha-glucosidases
  - m7G(5')pppAm-capped,polyadenylated-mRNA9
  - 'O-glycosyl 3a '
  - 'm7GpppA-mRNA9 '
  - 'm7G(5'')pppAm-mRNA7 '
  - 'NHC '
  - pp1ab-nsp10
  - 'PARP8 '
  - 'GSK3B '
  - pp1a
  - NAM
  - 'glycosylated-ACE2 '
  - 'SUMO1-C93-UBE2I '
  - 'Li<sup>+</sup> '
  - N-glycan M
  - nsp16:VHL
  - 'pp1a-nsp7 '
  - 'trimmed N-glycan-PALM-Spike '
  - 'CHMP2B '
  - 'ST3GAL2 '
  - trimmed unfolded
  - pp1ab-nsp7
  - 'CHMP6 '
  - 8b:MAP1LC3B
  - 'UBB(153-228) '
  - nsp15 hexamer
  - pp1a-nsp7
  - 'complex N-glycan-PALM-Spike S1 Fragment '
  - 'm7GpppA-mRNA8 '
  - CMP
  - '8b '
  - GSK3
  - nsp1
  - 'UBC(1-76) '
  - SARS-CoV-1 gRNA
  - MAP1LC3B
  - tetramer
  - 'm7G(5'')pppAm-capped,polyadenylated mRNA3 '
  - 'ST6GAL1 '
  - H+
  - pp1a-nsp6
  - GalNAc-O-3a
  - SUMO-p-Ncap
  - 'm7G(5'')pppAm-capped,polyadenylated mRNA5 '
  - nsp3-4
  - dimer:SARS
  - 'pp1ab-nsp2 '
  - p-S177,S181,S185,S187,S189,S191,S195,T199,S203,S207-N
  - pp1ab-nsp5
  - nascent E
  - N-glycan-PALM-Spike
  - RTC inhibitors
  - PARPs
  - N-glycan nsp4
  - 'mRNA6 '
  - nsp9 dimer
  - ESCRT-III
  - UBE2I
  - 'N-glycan M '
  - TMPRSS2:TMPRSS2
  - complement (minus
  - 'complex N-glycan-PALM-Spike '
  - m7G(5')pppAm-capped,polyadenylated mRNA4
  - 'mRNA8 '
  - 'UBC(77-152) '
  - beta-D-glucose
  - pp1ab-nsp13
  - genomic RNA (plus
  - 'm7G(5'')pppAm-capped,polyadenylated mRNA8 '
  - 'UBB(1-76) '
  - 5'-diphosphate(3-)
  - pp1ab-nsp8
  - 'mRNA5 '
  - RNA (plus strand)
  - 'MAP1LC3B '
  - RNA minus
  - plus strand
  - 'PARP6 '
  - 'mRNA7 '
  - 'PARP14 '
  - 'cepharanthine '
  - GSKi
  - SARS-CoV-1
  - 'GANAB '
  - CQ2+, HCQ2+
  - 'pp1ab-nsp3 '
  - nsp13:DDX5
  - N-glycan Spike
  - 7a:O-glycosyl
  - strand subgenomic
  - Pi
  - 'PARP10 '
  - M lattice
  - 'UBA52(1-76) '
  - m7G(5')pppAm-capped,polyadenylated mRNA5
  - Î±-Ketoamides
  - nsp7:nsp8
  - 'm7GpppA-capped SARS-CoV-1 genomic RNA (plus strand) '
  - 'pp1a '
  - RTC
  - 'pp1a-nsp3-4 '
  - gRNA:RTC:nascent
  - 5'-diphosphate(3âˆ’)
  - 'pp1a-nsp1-4 '
  - S-adenosyl-L-homocysteine
  - 'camostat '
  - NTP
  - 'CTSL(114-288) '
  - 'pp1ab-nsp6 '
  - CQ, HCQ
  - ATP
  - 'pp1ab-nsp3-4 '
  - inhibitors
  - 'm7G(5'')pppAm-capped,polyadenylated-mRNA9 '
  - RNA:7a:O-glycosyl
  - 'teicoplanin '
  - 'ST6GALNAC2 '
  - SUMO1-K62-p-S177-Ncap dimer
  - SARS-CoV-1 gRNA:RTC
  - 'm7G(5'')pppAm-mRNA9 '
  - PPi
  - Host Derived Lipid
  - 'complex N-glycan-PALM-Spike S2 Fragment '
  - 'PIK3R4 '
  - glucosidases:ER-alpha glucosidase inhibitors
  - VCP
  - 3a tetramer
  - NMP
  - 'ST6GALNAC3 '
  - N-glycan nsp3-4
  - RNA:O-glycosyl 3a
  - 'GSK3A '
  - 'N-glycan pp1ab-nsp3 '
  - 'N-glycan pp1a-nsp4 '
  - gRNA:RTC:RNA primer
  - 'Ub-3xPalmC-E '
  - 'PIK3C3 '
  - SARS
  - 'mRNA4 '
  - UVRAG complex
  - 'pp1ab-nsp8 '
  - m7G(5')pppAm-capped,
  - CANX
  - 'UBB(77-152) '
  - 'PARP4 '
  - nsp8:MAP1LC3B
  - 'ST3GAL1 '
  - RNA minus strand
  - nascent M
  - 'RPS27A(1-76) '
  - 'CQ2+ '
  - SARS coronavirus
  - ER-alpha
  - nucleotide
  - 'VHL '
  - 'm7G(5'')pppAm-capped SARS-CoV-1 genomic RNA complement (minus strand) '
  - 'mRNA2 '
  - 'mRNA3 '
  - ER-alpha-glucosidase
  - Bilayer Membrane
  - 'pp1ab-nsp1 '
  - 'N-glycan pp1ab-nsp4 '
  - 'HCQ '
  - 'pp1ab-nsp7 '
  - 7a
  - nsp7:nsp8:nsp12:nsp14:nsp10
  - GTP
  - pp1ab-nsp3-4
  - N-glycan
  - 'm7G(5'')pppAm-mRNA6 '
  - structure
  - nucleotide-sugar
  license: CC0
  name: SARS-CoV-1 Infection
seo: CreativeWork
title: SARS-CoV-1 Infection
wpid: WP5020
---